Treatment Times in Salivary Gland Cancer: National Patterns and Association with Survival

Abstract

Objective To characterize treatment times in salivary cancer; associate treatment times with patient, tumor, and treatment characteristics; and examine the association of treatment times and overall survival. Study Design Retrospective cohort. Setting Commission-on-Cancer Accredited Hospitals 2004-2013. Subjects and Methods In total, 5953 patients with salivary cancer included in the National Cancer Database were identified. For each treatment interval, patients in the fourth quartile ("prolonged") were compared to patients in the first and second quartiles ("not prolonged"). Patient, tumor, and treatment characteristics were associated with prolonged times via multivariable binary logistic regression. Prolongation of each interval was associated with overall survival via multivariable Cox proportional hazards regression, controlling for clinically relevant factors. Results Median durations for diagnosis-to-treatment initiation, surgery-to-radiation treatment (RT), RT duration, total treatment package, and diagnosis-to-treatment end were 31, 44, 47, 92, and 110 days, respectively. Race, insurance status, comorbidities, age, T and N stage, facility volume and location, and a facility care transition from diagnosis to initial treatment were associated with prolonged treatment time. Prolonged RT duration was associated with decreased overall survival (OS) (62% vs 75% 5-year OS, HR = 1.26 [95% confidence interval (CI), 1.09-1.47]; P = .002), but prolonged diagnosis-to-treatment initiation, surgery-to-RT, total treatment package, and diagnosis-to-treatment end intervals were not (70% vs 67% 5-year OS, HR = 1.11 [95% CI, 0.92-1.34], P = .284; 72% vs 68%, HR = 0.93 [95% CI, 0.79-1.09], P = .370; 70% vs 70%, HR = 1.00 [95% CI, 0.84-1.20], P = .974; 66% vs 71%, HR = 0.99 [95% CI, 0.84-1.18], P = .920, respectively). Conclusion The median durations identified here can serve as reference points. Radiation therapy duration is associated with overall survival in salivary cancer and could be considered a quality indicator.

Margins in Sinonasal Squamous Cell Carcinoma: Predictors, Outcomes, and the Endoscopic Approach

“…However, facilities with higher volumes of SNSCC were associated with decreased risk of positive margins, likely a result of increased anatomic familiarity and multidisciplinary teams that can better inform surgical technique . This bolsters evidence from previous studies demonstrating favorable prognostic factors for head and neck cancer when treated at HVFs and academic centers, as has been seen in many other head and neck cancer subsites …”

Treatment delays in surgically managed sinonasal cancer and association with survival

“…Of the multiple factors that may underlie prolonged DTS, care transitions appear to play a major role in sinonasal cancer. Patients in our study more commonly received treatment at a site other than the diagnosing facility (61%) compared to studies of salivary (33%), laryngeal (39%), or hypopharyngeal (43%) cancer using the same database. Such care transitions were among the strongest predictors of prolonged DTS.…”

“…Treatment delay is associated with decreased disease control and survival, potentially driven by cancer stage progression or tumor cell repopulation after surgery prolonged treatment times . Although recent studies have analyzed treatment intervals for several different head and neck subsites, the impact of treatment delays in sinonasal cancer has yet to be elucidated.…”

Framework for prioritizing head and neck surgery during the COVID‐19 pandemic

“…Finally, the delay of thyroid surgery is often safely delayed until after delivery in pregnant patients without compromising oncologic outcomes 40 . Among salivary cancer (all histologies and grades), a national retrospective review found that TTI had no impact on 5‐year overall survival 41 …”